Biotech

All Articles

Basilea scores $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's work developing brand new antifungals has gotten a significant boost from t...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Possessing actually scooped up the USA legal rights to Capricor Therapies' late-stage Duchenne musc...

FDA scraps adcomm for Applied's uncommon ailment medication

.After dismissing the decision meeting for Applied Rehabs' metabolic disorder medication govorestat,...

Novo inks $600M NanoVation package to research genetic medicines ex-liver

.Novo Nordisk is continuing its press into hereditary medications, accepting compensate NanoVation T...

Innovent hyperlinks cytokine to colorectal cancer cells feedbacks

.Innovent Biologics has actually made the case that its checkpoint inhibitor-cytokine fusion protein...

Merck, Daiichi ADC reaches target in phase 3 bronchi cancer study

.A phase 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens AI center with collab to select cancer targets

.Five months after Rakovina Therapies pivoted towards artificial intelligence, the cancer-focused bi...

Ascendis' dwarfism medication hits in stage 3, intimidates BioMarin

.Ascendis Pharma has emerged as a potential threat to BioMarin's Voxzogo, stating phase 3 growth dis...

Despite ph. 3 miss, Alkeus finds pathway in advance for eye disease property

.Though Alkeus Pharmaceuticals' dental eye disease asset fell short to significantly lessen geograph...

Kairos goes social along with $6M IPO to money trials of cancer cells medicine

.With a triad of biotechs striking the Nasdaq on Friday, it was actually quick and easy to miss out ...